• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.390 +0.040 (+0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,220
Open 6.330
Bid (Size) 6.390 (1)
Ask (Size) 10.00 (69)
Prev. Close 6.350
Today's Range 6.230 - 6.450
52wk Range 4.540 - 10.79
Shares Outstanding 61,331,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf
October 30, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
October 27, 2025
From Grabar Law Office
Via GlobeNewswire

Performance

YTD
-18.8%
-18.8%
1 Month
+1.1%
+1.1%
3 Month
+19.7%
+19.7%
6 Month
-12.0%
-12.0%
1 Year
+37.1%
+37.1%

More News

Read More
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Scheduled For August 7, 2025
August 07, 2025
Via Benzinga
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
October 14, 2025
From Grabar Law Office
Via GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
October 13, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Fluor Corporation (NYSE: FLR); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims
September 30, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating
September 26, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your
September 15, 2025
From Grabar Law Office
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
September 10, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); SelectQuote, Inc. (NYSE: SLQT); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
September 08, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Napco Security Technologies, Inc. (NASDAQ: NSSC); SelectQuote, Inc. (NYSE: SLQT); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your
September 02, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta, Inc. (NYSE: IBTA); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims
August 19, 2025
From Grabar Law Office
Via GlobeNewswire
Treace Medical (TMCI) Q2 Revenue Up 7%
August 07, 2025
Via The Motley Fool
Treace Medical Concepts Reports Second Quarter 2025 Financial Results
August 07, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
August 07, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating
August 06, 2025
From Grabar Law Office
Via GlobeNewswire
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
August 05, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating
August 05, 2025
From Grabar Law Office
Via GlobeNewswire
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your Behalf
July 23, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR); Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims
July 21, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Napco Security Technologies, Inc, (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating
July 18, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); Hims & Hers, Inc. (NYSE: HIMS); Petco Health & Wellness Company, Inc. (NASDAQ: WOOF); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating
July 17, 2025
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is
July 14, 2025
From Grabar Law Office
Via GlobeNewswire

Frequently Asked Questions

Is Treace Medical Concepts, Inc. - Common Stock publicly traded?
Yes, Treace Medical Concepts, Inc. - Common Stock is publicly traded.
What exchange does Treace Medical Concepts, Inc. - Common Stock trade on?
Treace Medical Concepts, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Treace Medical Concepts, Inc. - Common Stock?
The ticker symbol for Treace Medical Concepts, Inc. - Common Stock is TMCI on the Nasdaq Stock Market
What is the current price of Treace Medical Concepts, Inc. - Common Stock?
The current price of Treace Medical Concepts, Inc. - Common Stock is 6.390
When was Treace Medical Concepts, Inc. - Common Stock last traded?
The last trade of Treace Medical Concepts, Inc. - Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Treace Medical Concepts, Inc. - Common Stock?
The market capitalization of Treace Medical Concepts, Inc. - Common Stock is 391.91M
How many shares of Treace Medical Concepts, Inc. - Common Stock are outstanding?
Treace Medical Concepts, Inc. - Common Stock has 392M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap